Korro Bio, Inc. (KRRO) stock
KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.32−0.39 (-3.07%)
Close on Nov 17, 2026Market cap $181.42MP/E –Yield –
Korro Bio operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Korro Bio's operating cash flow for the twelve months ending Jun 30, 2026 was -$67.95M. For fiscal 2025 it was -$78.56M. The highest annual figure on record is $34.22M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$78.56M | – |
| FY2024 | Dec 31, 2024 | -$60.07M | – |
| FY2023 | Dec 31, 2023 | -$67.28M | – |
| FY2022 | Dec 31, 2022 | -$53.65M | – |
| FY2021 | Dec 31, 2021 | -$76.06M | – |
| FY2020 | Dec 31, 2020 | -$45.19M | -232.1% |
| FY2019 | Dec 31, 2019 | $34.22M | – |
| FY2018 | Dec 31, 2018 | -$17.02M | – |
| FY2017 | Dec 31, 2017 | -$14.61M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$16.99M | – |
| Q1 FY2026 | Mar 31, 2026 | -$16.07M | – |
| Q4 FY2025 | Dec 31, 2025 | -$17.70M | – |
| Q3 FY2025 | Sep 30, 2025 | -$17.18M | – |
| Q2 FY2025 | Jun 30, 2025 | -$19.23M | – |
| Q1 FY2025 | Mar 31, 2025 | -$24.45M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.50M | – |
| Q3 FY2024 | Sep 30, 2024 | -$16.10M | – |
| Q2 FY2024 | Jun 30, 2024 | -$14.59M | – |
| Q1 FY2024 | Mar 31, 2024 | -$21.89M | – |
| Q4 FY2023 | Dec 31, 2023 | -$21.11M | – |
| Q3 FY2023 | Sep 30, 2023 | -$11.77M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.72M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.69M | – |
| Q4 FY2022 | Dec 31, 2022 | -$11.03M | – |
| Q3 FY2022 | Sep 30, 2022 | -$11.80M | – |
| Q2 FY2022 | Jun 30, 2022 | -$13.48M | – |
| Q1 FY2022 | Mar 31, 2022 | -$17.34M | – |
| Q4 FY2021 | Dec 31, 2021 | -$17.89M | – |
| Q3 FY2021 | Sep 30, 2021 | -$15.02M | – |
| Q2 FY2021 | Jun 30, 2021 | -$17.67M | – |
| Q1 FY2021 | Mar 31, 2021 | -$25.47M | – |
| Q4 FY2020 | Dec 31, 2020 | -$14.83M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.73M | -114.4% |
| Q2 FY2020 | Jun 30, 2020 | -$10.26M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$29.74M | – |
| Q3 FY2019 | Sep 30, 2019 | $74.58M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.47M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.15M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.72M | – |
See a number that looks wrong?